Current RNA strategies in treating cardiovascular diseases

Area of Science:

• Cardiovascular Medicine
• Molecular Biology
• RNA Therapeutics

Background:

• Cardiovascular disease (CVD) remains a major global health challenge.
• Current treatments often fall short for complex molecular mechanisms.
• Innovative therapeutic strategies are urgently needed.

Purpose of the Study:

• To review the current landscape of RNA therapeutics for cardiovascular disease (CVD).
• To identify common gene targets for both Mendelian and acquired CVD.
• To discuss challenges and opportunities in RNA therapeutic delivery to the cardiovascular system.

Main Methods:

• Comprehensive literature review of RNA-based therapeutic modalities.
• Analysis of gene targets relevant to CVD pathogenesis.
• Evaluation of RNA delivery strategies for cardiovascular applications.

Main Results:

• RNA therapeutics offer transient or permanent modifications by targeting the central dogma.
• Identified common gene targets for Mendelian and acquired CVD.
• Delivery strategies present key challenges and opportunities for cardiovascular targeting.

Conclusions:

• RNA-based interventions represent a novel and precise approach to combat CVD.
• Targeted gene therapies hold significant potential for future cardiovascular therapeutics.
• Further research into delivery mechanisms is crucial for clinical translation.